Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
9 January 2026
1 min read

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

NEW YORK, Jan 9, 2026, 14:11 EST — Regular session

  • Kohl’s shares are down about 5% in afternoon trading after opening in the green
  • Retailers keep tabs on tariff uncertainty after Supreme Court delays a decision
  • The jobs report keeps the Fed’s path in view, but tariffs are still the wild card

Kohl’s Corp (KSS) shares were off roughly 5.1% at $20.66 Friday afternoon, after a choppy session that ran from $22.27 down to $20.43. The department-store operator opened at $22.00.

The stock trailed even as the broader market found its footing after a softer U.S. jobs report. The U.S. Supreme Court said it would not issue a ruling on Friday on the legality of President Donald Trump’s sweeping tariffs, leaving investors still waiting on clarity around duties that can shift costs for import-heavy retailers. 1

Importers and trade lawyers are girding for a ruling that could unleash claims for about $150 billion in tariff refunds. U.S. Customs and Border Protection is set to move refund payments to electronic distribution on Feb. 6. Companies, though, still see a battle ahead over when money goes out and who qualifies. “It’s not in the government’s DNA to give back money,” said Jim Estill, CEO of Danby Appliances. 2

Kohl’s drop outpaced several retail peers. Under Armour sank about 6.3%, Macy’s slid 2.3%, and Target was off about 0.8%.

Nonfarm payrolls, which track jobs added outside agriculture, rose 50,000 in December, and the unemployment rate edged down to 4.4%, according to a Labor Department report. The figures kept expectations intact that the Fed would hold rates steady at its Jan. 27-28 meeting. “All roads lead to the unemployment rate … it should douse the Fed’s recent urgency to backstop a weakening labor market,” said Olu Sonola, head of U.S. economic research at Fitch Ratings. 3

Kohl’s stock jumped 5.38% Thursday, ending the session at $21.76. Even after the pop, it was still about 14% below its 52-week high of $25.22, set on Dec. 1. MarketWatch data showed Thursday’s trading volume came in under its 50-day average.

Tariffs are a big deal for retailers because they push up the price of imported clothes and home goods, leaving companies to either eat the cost or pass it along. However they handle it, the pressure shows up in the same spot: margins and demand.

Even so, a court decision may not be the last word on tariffs. Michael Browne at Franklin Templeton told Reuters he expects duties to come back “pretty quickly,” and said any ruling would likely just push the effort onto another track rather than end it outright. 4

Traders are circling Jan. 14, when the Supreme Court is due to hand down its next rulings, as the tariff case remains pending after arguments in November. 5

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Nike stock edges up after RTFKT sale report, even as a downgrade warns the turnaround is slow
Previous Story

Nike stock edges up after RTFKT sale report, even as a downgrade warns the turnaround is slow

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus
Next Story

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Go toTop